IPSC vs SPGI · rev $6.6M vs P/E 27, rev $15.34B
Century Therapeutics Inc (IPSC) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
IPSC currently screens at market cap $47.8M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the IPSC and SPGI stock pages for the full models.
Not investment advice.